Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

15.990
-0.510-3.09%
Volume:5.74M
Turnover:91.72M
Market Cap:42.52B
PE:10.80
High:16.480
Open:16.480
Low:15.800
Close:16.500
52wk High:28.232
52wk Low:14.505
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:0.99
T/O Rate:1.06%
Dividend:0.45
Dividend Rate:2.84%
EPS(LYR):1.481
ROE:6.95%
ROA:1.40%
PB:0.75
PE(LYR):10.80
PS:0.86

Loading ...

Fosun Pharma's Vaccine Unit Submits Hong Kong Listing Application

MT Newswires Live
·
Jun 29

Fosun Pharma Seeks Approval to List Subsidiary Fosun Antigen on Hong Kong Main Board

Stock News
·
Jun 26

Shanghai Fosun Pharma - Co was Informed That Fosun Adgenvax Submitted Listing Application for Listing of Its H Shares on HKEX Main Board

THOMSON REUTERS
·
Jun 26

Sinopharm Group Stock Advances 1.1% in Hong Kong

Dow Jones
·
Jun 24

Sinopharm Group Stock Falls 2.7% in Hong Kong

Dow Jones
·
Jun 18

Fosun Pharma Unit Passes GMP Inspection

MT Newswires Live
·
Jun 18

Fosun Pharma Gets China Nod to Trial HLX3902 Injection

MT Newswires Live
·
Jun 18

Fosun Pharma Subsidiary Passes GMP Compliance Inspection

Stock News
·
Jun 17

Fosun Pharma Announces Final Dividend of RMB 0.39 Per Share for Payment on August 14

Stock News
·
Jun 16

Fosun Pharma Secures Shareholder Support for All AGM Proposals; Announces RMB0.39 Final Dividend

Bulletin Express
·
Jun 16

Fosun Pharma Unit's Luvometinib Gets China Nod for Langerhans Cell Histiocytosis Drug Indication

MT Newswires Live
·
Jun 16

Fosun Pharma Showcases Strategy at Abu Dhabi Forum, Highlighting Innovation and Collaboration as Key to China-UAE Healthcare Partnership

Deep News
·
Jun 15

Fosun Pharma secures NMPA nod for Luvometinib’s pediatric LCH indication, lifting rare-tumor portfolio

Bulletin Express
·
Jun 15

Shanghai Fosun Pharma - Drug Registration Application for Additional Indication of Luvometinib Tablets Approved by Nmpa

THOMSON REUTERS
·
Jun 15

Fosun Pharma's Shareholder Meeting Hints at Major Moves: Billions in Guarantees and Dual A/H Share Buybacks Revealed

Deep News
·
Jun 13

Sinopharm Group Stock Falls 1.6% in Hong Kong

Dow Jones
·
Jun 11

FOSUN INTL's "Strongest Valuation Anchor" Solidifies as Innovative Drug R&D and Commercialization Accelerates

Stock News
·
Jun 03

Subsidiary of FOSUN PHARMA Gains Approval for Pertuzumab Injection

Stock News
·
May 29

FOSUN PHARMA Invests Over 400 Million Yuan in Nucleic Acid Drug Firm

Deep News
·
May 27

Sinopharm Group Stock Falls 1.7% in Hong Kong

Dow Jones
·
May 27